Skip to main content

Intellia Therapeutics  (NTLA)  shares were flying high ahead of market's open Tuesday, up more than 5% after a positive trading day Monday.

The gene editing biotech announced that the European Patent Office has granted the company a patent for its CRISPR/Cas9 genome editing technology.

The company's shares were up 5.5% ahead of the opening bell, hitting $14.49 apiece Tuesday.

Teligent   (TLGT)  , meanwhile, was up 3.3% ahead of the opening bell. Shares were trading at $8.66 apiece before markets opened.

This was after the company barely moved on Monday.

Insys Therapeutics   (INSY)   also made positive moves ahead of market's open Tuesday after having a positive trading day Monday.

Shares were up nearly 2% ahead of market's open, hitting $11.23 apiece. This was after Insys was up 6.5% Monday. Insys focuses on researching the use of cannabis for therapeutics.

Microcap Novavax   (NVAX)   made positive moves ahead of the opening bell Tuesday as well. Shares were up 4.4% ahead of market's opening, hitting 94 cents apiece. The company's focus is vaccines.